ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Conditions
Hepatocellular Carcinoma (HCC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
The First Affiliated Hospital of USTC, Hefei, Anhui, China
The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality, China
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Chongqing university cancer hospital, Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China
Liuzhou People's Hospital, Liuzhou, Guangxi, China
Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China
Guizhou Provincial People's Hospital, Guiyang, Guizhou, China
Affiliated Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang, China
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, Henan, China
Henan Cancer Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Hubei Cancer Hospital, Wuhan, Hubei, China
Tongji Hospital, Wuhan, Hubei, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
Hunan Cancer Hospital, Changsha, Hunan, China
General Hospital of Easten Theater Command, Nanjing, Jiangsu, China
Nanjing Tianyinshan Hospital, Nanjing, Jiangsu, China
The First Affiliated Hospital with NanJing Medical University, Nanjing, Jiangsu, China
Nantong Tumor Hospital, Nantong, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China
Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Jilin Cancer Hospital, Changchun, Jilin, China
The First Hospital of Jilin University, Changchun, Jilin, China
Liaoning Cancer Hospital, Shenyang, Liaoning, China
Contact: Principal Investigator (Jingdong Zhang)The First Hospital of China Medical University, Shenyang, Liaoning, China
General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
Shandong Cancer Hospital, Jinan, Shandong, China
Affiliated Hospital ofJining Medical University, Jining, Shandong, China
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai Municipality, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Renji Hospital,Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China
Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
Shanxi Cancer Hospital, Taiyuan, Shanxi, China
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Mianyang Central Hospital, Mianyang, Sichuan, China
TianJin Cancer Hospital Airport Hospital, Tianjin, Tianjin Municipality, China
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China